Clinical utility of circulating tumor cells: An update

A Vasseur, N Kiavue, FC Bidard, JY Pierga… - Molecular …, 2021 - Wiley Online Library
The prognostic role of circulating tumor cells (CTCs) has been clearly demonstrated in many
types of cancer. However, their roles in diagnostic and treatment strategies remain to be …

Circulating tumor cells: clinical validity and utility

L Cabel, C Proudhon, H Gortais, D Loirat… - International journal of …, 2017 - Springer
Circulating tumor cells (CTCs) are rare tumor cells and have been investigated as
diagnostic, prognostic and predictive biomarkers in many types of cancer. Although CTCs …

[HTML][HTML] Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis

D Tan, Y Fu, W Tong, F Li - International journal of surgery, 2018 - Elsevier
Purpose The lymphocyte to monocyte ratio, an inflammation-based score, has been used to
predict the biological behavior of malignant tumors. However, the relationship between the …

Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer

D Dayde, I Tanaka, R Jain, MC Tai… - International journal of …, 2017 - mdpi.com
The standard of care in locally advanced rectal cancer is neoadjuvant chemoradiation
(nCRT) followed by radical surgery. Response to nCRT varies among patients and …

Improving the CellSearch® system

JF Swennenhuis, G van Dalum, LL Zeune… - Expert review of …, 2016 - Taylor & Francis
ABSTRACT Introduction: The CellSearch® CTC test enumerates tumor cells present in 7.5
ml blood of cancer patients. improvements, extensions and different utilities of the cellsearch …

Current applications and future directions of circulating tumor cells in colorectal cancer recurrence

KY Tsai, PS Huang, PY Chu, TNA Nguyen, HY Hung… - Cancers, 2024 - mdpi.com
Simple Summary The ability to predict or detect colorectal cancer (CRC) recurrence early
after surgery enables physicians to apply appropriate treatment plans and different follow-up …

Circulating tumor cells in gastrointestinal cancers: current status and future perspectives

C Yang, F Chen, S Wang, B Xiong - Frontiers in oncology, 2019 - frontiersin.org
Circulating tumor cells (CTCs), which are now defined as the “break away” cancer cells that
derive from primary-or metastatic-tumor sites and present in the bloodstream, are …

[HTML][HTML] Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy

W Sun, G Li, J Wan, J Zhu, W Shen, Z Zhang - Oncotarget, 2016 - ncbi.nlm.nih.gov
Purpose The aim of this study was to investigate the role of circulating tumor cells (CTCs) in
assessing and predicting tumor response to neoadjuvant chemoradiotherapy (CRT) for …

Circulating tumor cells and circulating tumor DNA: what surgical oncologists need to know?

L Cabel, C Proudhon, P Mariani, D Tzanis… - European Journal of …, 2017 - Elsevier
As a result of recent progress in detection techniques, circulating tumor DNA (ctDNA) and
circulating tumor cells (CTC) can now be accurately detected in the blood of most cancer …

[HTML][HTML] Clinical and pathological characteristics and prognosis of 132 cases of rectal neuroendocrine tumors

YJ Yu, YW Li, Y Shi, Z Zhang, MY Zheng… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Neuroendocrine tumors (NETs) frequently occur in the gastrointestinal tract,
lung, and pancreas, and the rectum and appendix are the sites with the highest incidence …